Login / Signup

Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study.

Alice BurgevinBénédicte CaronAlexa SassonAmandine LucPatrick NetterCédric BaumannAshwin N AnanthakrishnanLaurent Peyrin-Biroulet
Published in: Journal of clinical medicine (2022)
Safety was similar between vedolizumab and ustekinumab in older patients with inflammatory bowel disease.
Keyphrases
  • patients with inflammatory bowel disease
  • community dwelling
  • physical activity
  • middle aged